Literature DB >> 33547768

Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation.

Nanon F L Heijnen1, Laura A Hagens2, Marry R Smit2, Marcus J Schultz2,3,4,5, Tom van der Poll6,7, Ronny M Schnabel1, Iwan C C van der Horst1, Robert P Dickson8,9,10, Dennis C J J Bergmans1, Lieuwe D J Bos2.   

Abstract

Biological subphenotypes have been identified in acute respiratory distress syndrome (ARDS) based on two parsimonious models: the "uninflamed" and "reactive" subphenotype (cluster-model) and "hypo-inflammatory" and "hyper-inflammatory" (latent class analysis (LCA) model). The distinction between the subphenotypes is mainly driven by inflammatory and coagulation markers in plasma. However, systemic inflammation is not specific for ARDS and it is unknown whether these subphenotypes also reflect differences in the alveolar compartment. Alveolar inflammation and dysbiosis of the lung microbiome have shown to be important mediators in the development of lung injury. This study aimed to determine whether the "reactive" or "hyper-inflammatory" biological subphenotype also had higher concentrations of inflammatory mediators and enrichment of gut-associated bacteria in the lung. Levels of alveolar inflammatory mediators myeloperoxidase (MPO), surfactant protein D (SPD), interleukin (IL)-1b, IL-6, IL-10, IL-8, interferon gamma (IFN-ƴ), and tumor necrosis factor-alpha (TNFα) were determined in the mini-BAL fluid. Key features of the lung microbiome were measured: bacterial burden (16S rRNA gene copies/ml), community diversity (Shannon Diversity Index), and community composition. No statistically significant differences between the "uninflamed" and "reactive" ARDS subphenotypes were found in a selected set of alveolar inflammatory mediators and key features of the lung microbiome. LCA-derived subphenotypes and stratification based on cause of ARDS (direct vs. indirect) showed similar profiles, suggesting that current subphenotypes may not reflect the alveolar host response. It is important for future research to elucidate the pulmonary biology within each subphenotype properly, which is arguably a target for intervention.
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33547768      PMCID: PMC7865405          DOI: 10.14814/phy2.14693

Source DB:  PubMed          Journal:  Physiol Rep        ISSN: 2051-817X


  28 in total

1.  Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; Catherine A Lozupone; Peter J Turnbaugh; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

Review 2.  Biological markers of acute lung injury: prognostic and pathogenetic significance.

Authors:  J F Pittet; R C Mackersie; T R Martin; M A Matthay
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

Review 3.  Acute Respiratory Distress Syndrome.

Authors:  B Taylor Thompson; Rachel C Chambers; Kathleen D Liu
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

4.  Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.

Authors:  Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

5.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

6.  Peripheral and Alveolar Cell Transcriptional Programs Are Distinct in Acute Respiratory Distress Syndrome.

Authors:  Eric D Morrell; Frank Radella; Anne M Manicone; Carmen Mikacenic; Renee D Stapleton; Sina A Gharib; Mark M Wurfel
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

7.  Cytokine balance in the lungs of patients with acute respiratory distress syndrome.

Authors:  W Y Park; R B Goodman; K P Steinberg; J T Ruzinski; F Radella; D R Park; J Pugin; S J Skerrett; L D Hudson; T R Martin
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

8.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Authors:  Carolyn S Calfee; Kevin L Delucchi; Pratik Sinha; Michael A Matthay; Jonathan Hackett; Manu Shankar-Hari; Cliona McDowell; John G Laffey; Cecilia M O'Kane; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2018-08-02       Impact factor: 30.700

9.  Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome.

Authors:  G U Meduri; G Kohler; S Headley; E Tolley; F Stentz; A Postlethwaite
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

10.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more
  3 in total

1.  Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation.

Authors:  Nanon F L Heijnen; Laura A Hagens; Marry R Smit; Marcus J Schultz; Tom van der Poll; Ronny M Schnabel; Iwan C C van der Horst; Robert P Dickson; Dennis C J J Bergmans; Lieuwe D J Bos
Journal:  Physiol Rep       Date:  2021-02

2.  Assessment of Alveolar Macrophage Dysfunction Using an in vitro Model of Acute Respiratory Distress Syndrome.

Authors:  Rahul Y Mahida; Aaron Scott; Dhruv Parekh; Sebastian T Lugg; Kylie B R Belchamber; Rowan S Hardy; Michael A Matthay; Babu Naidu; David R Thickett
Journal:  Front Med (Lausanne)       Date:  2021-09-29

Review 3.  Towards a biological definition of ARDS: are treatable traits the solution?

Authors:  Lieuwe D J Bos; John G Laffey; Lorraine B Ware; Nanon F L Heijnen; Pratik Sinha; Brijesh Patel; Matthieu Jabaudon; Julie A Bastarache; Daniel F McAuley; Charlotte Summers; Carolyn S Calfee; Manu Shankar-Hari
Journal:  Intensive Care Med Exp       Date:  2022-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.